White label ELPA - ClinicalTrials.eu

A Phase 2b/3 Randomized Double‑Blind Study of Ataciguat to Slow Disease Progression in Adults with Moderate Calcific Aortic Valve Stenosis

Not yet recruiting

3 1 1
Investigated diseases:
- Aortic valve stenosis
+1
Study of PF-07275315 versus placebo for efficacy and safety in adults with moderate-to-severe chronic obstructive pulmonary disease (COPD)

Not yet recruiting

2 1
Investigated diseases:
- Chronic obstructive pulmonary disease
+3
Rituximab versus clinic‑biological monitoring for ANCA reactivation in patients with GPA or MPA (with prednisolone)

Not yet recruiting

3 1 1 1
Investigated diseases:
- Granulomatosis with polyangiitis
- Microscopic polyangiitis
Investigated drugs:
- Prednisolone
- Rituximab
Cannabidiol for Alcohol Dependence in Adults Seeking Abstinence: A Phase II Placebo‑Controlled Trial

Not yet recruiting

2 1
Investigated diseases:
- Alcohol abuse
Investigated drugs:
- CANNABINOL
Study of Oral Misoprostol Combined with Osmotic Dilators for Labour Induction in Women with an Unprepared Cervix

Not yet recruiting

3 1 1 1
Investigated diseases:
- Labour induction
Investigated drugs:
- Misoprostol
Long-term safety and outcomes of repeated rituximab in adults with schizophrenia spectrum disorder

Not yet recruiting

2 1 1 1
Investigated diseases:
- Schizophrenia
Investigated drugs:
- Rituximab
Safety and Tolerability of Oral SUN-627 in Adults with Non‑Active Progressive Multiple Sclerosis (SPMS/PPMS) – Phase 2a Study

Not yet recruiting

2 1 1
Investigated diseases:
- Multiple sclerosis
Diagnostic Accuracy of [18F]FAPI-74 PET/CT for Detecting Metastasis and Assessing Treatment Response in Gastric Cancer Patients

Not yet recruiting

2 1 1
Investigated diseases:
- Gastric cancer
Investigated drugs:
- [Al[18F]F]Fapi-74
Postoperative oxaliplatin liver‑directed chemotherapy plus drug combination in patients with resected colorectal liver metastases at high risk of recurrence

Not yet recruiting

3 1 1 1
Investigated diseases:
- Colorectal cancer metastatic
Investigated drugs:
Evaluating Gradual Interval Extension of Tezepelumab in Drug Combination for Patients with Severe Asthma

Not yet recruiting

3 1 1 1
Investigated diseases:
- Asthma
Investigated drugs:

Full Name *

e-Mail *

Country Prefix *

Phone Number *

Nationality *

Gender *

Check all consents

Check all consents

I accept the Terms and Conditions and Privacy Policy *

*I accept the Terms and Conditions and Privacy Policy

I consent to receiving commercial information from the Service Operator *

*I consent to receiving commercial information from the Service Operator

I consent to the use of telecommunications terminal equipment and automated calling systems by the Service Operator for marketing communication purposes *

*I consent to the use of telecommunications terminal equipment and automated calling systems by the Service Operator for marketing communication purposes

We use cookies